✦ LIBER ✦

P95 Neoadjuvant Doxorubicin followed sequentially by Cisplatin-Docetaxel in locally advanced breast cancer

✍ Scribed by A. Ezzat; M. Rahal; D. Ajarim; A. Al-Sayed; A. Tulbah; O. Al-Malik; M. Al-Shabana; T. Al-Tweigeri

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective phase II study of neoadjuvan

✍ Taher A. Al-Tweigeri; Dahish S. Ajarim; Adher A. Alsayed; Mohamed M. Rahal; Moha 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 272 KB

Prospective phase II study of: neo-adjuv

✍ T. Al-Tweigeri; Rahal; D. Ajarim; A. Al-Sayed; A. Tulba; O. Al-Malik; M. Al-Shab 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Neoadjuvant Docetaxel in Locally Advance

✍ Andrew W. Hutcheon; Steven D. Heys; Tarun K. Sarkar 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 122 KB

Locally advanced breast cancer (LABC): n

✍ W. Wynendaele; R. Paridaens; J. Wildiers; M.R. Christiaens; W. Van den Bogaert; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Neoadjuvant and Adjuvant Chemotherapy wi

✍ Vikas Malhotra; Victoria J. Dorr; Alan P. Lyss; Clay M. Anderson; Steven Westgat 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 203 KB

434 Phase II Study of Neoadjuvant Pegyla

✍ M.K. Tuxen; S. Cold; U.B. Tange; S.B. Soendergaard; D.L. Nielsen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB